Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
Nigar Sekercioglu(University of Toronto), David Z.I. Cherney(University Health Network), Josephine Tse(University Health Network), Hillary A. Keenan(Joslin Diabetes Center), Leif E. Lovblom(University of Toronto), Petter Bjornstad(University of Colorado Denver), Leslie Cham(University Health Network), Vesta Lai(University Health Network), Narinder Paul(University Health Network), Yuliya Lytvyn(University Health Network), Andrej Orszag(University of Toronto), Vera Bril(University Health Network), Julie A. Lovshin(Sunnybrook Health Science Centre), Geneviève Boulet(University of Toronto), Bruce A. Perkins(Sinai Health System), Mohammed A. Farooqi(Mount Sinai Hospital), Michael H. Brent(University of Toronto)
Cited by 8
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
State of the Art: Iterative CT Reconstruction Techniques
|Radiology|2015|704
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
|Diabetes|2010|497
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470